Neurocrine Biosciences
NBIX
#1547
Rank
NZ$24.85 B
Marketcap
NZ$244.57
Share price
-0.39%
Change (1 day)
0.23%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company